The variants rs25487 (XRCC1), rs3218556 (XRCC2), and rs13181 (XPD) all contribute to the efficacy and toxicity of radiotherapy in patients with NSCLC [32]. This evidence concerns the gene XRCC1 and non-small cell lung carcinoma.